• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

勘误：用于2型糖尿病的基于血液的DNA甲基化生物标志物：临床应用潜力。

Corrigendum: Blood-Based DNA Methylation Biomarkers for Type 2 Diabetes: Potential for Clinical Applications.

作者信息

Willmer Tarryn, Johnson Rabia, Louw Johan, Pheiffer Carmen

机构信息

Biomedical Research and Innovation Platform, South African Medical Research Council, Tygerberg, South Africa.

Division of Medical Physiology, Faculty of Health Sciences, Stellenbosch University, Tygerberg, South Africa.

出版信息

Front Endocrinol (Lausanne). 2019 Jan 22;10:1. doi: 10.3389/fendo.2019.00001. eCollection 2019.

DOI:10.3389/fendo.2019.00001
PMID:30723457
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6349824/
Abstract

[This corrects the article DOI: 10.3389/fendo.2018.00744.].

摘要

[本文更正了文章的数字对象标识符：10.3389/fendo.2018.00744。]

相似文献

1
Corrigendum: Blood-Based DNA Methylation Biomarkers for Type 2 Diabetes: Potential for Clinical Applications.勘误：用于2型糖尿病的基于血液的DNA甲基化生物标志物：临床应用潜力。
Front Endocrinol (Lausanne). 2019 Jan 22;10:1. doi: 10.3389/fendo.2019.00001. eCollection 2019.
2
Corrigendum: Popular Diabetes Apps and the Impact of Diabetes App Use on Self-Care Behaviour: A Survey Among the Digital Community of Persons With Diabetes on Social Media.勘误：热门糖尿病应用程序以及糖尿病应用程序使用对自我护理行为的影响：一项针对社交媒体上糖尿病患者数字社区的调查。
Front Endocrinol (Lausanne). 2019 Apr 5;10:220. doi: 10.3389/fendo.2019.00220. eCollection 2019.
3
Blood-Based DNA Methylation Biomarkers for Type 2 Diabetes: Potential for Clinical Applications.用于2型糖尿病的基于血液的DNA甲基化生物标志物：临床应用潜力
Front Endocrinol (Lausanne). 2018 Dec 4;9:744. doi: 10.3389/fendo.2018.00744. eCollection 2018.
4
Corrigendum: Physiology and Pharmacology of DPP-4 in Glucose Homeostasis and the Treatment of Type 2 Diabetes.
Front Endocrinol (Lausanne). 2019 May 3;10:275. doi: 10.3389/fendo.2019.00275. eCollection 2019.
5
Corrigendum: Altered Gray Matter Volume in Patients With Type 1 Diabetes Mellitus.勘误：1型糖尿病患者灰质体积改变
Front Endocrinol (Lausanne). 2020 Aug 28;11:604. doi: 10.3389/fendo.2020.00604. eCollection 2020.
6
Corrigendum: Genome-wide DNA-methylation landscape defines specialization of regulatory T cells in tissues.勘误：全基因组DNA甲基化图谱定义了组织中调节性T细胞的特化。
Nat Immunol. 2017 Nov 16;18(12):1361. doi: 10.1038/ni1217-1361b.
7
Corrigendum: Placental Nutrient Transport in Gestational Diabetic Pregnancies.勘误：妊娠期糖尿病孕妇的胎盘营养转运
Front Endocrinol (Lausanne). 2019 Jan 28;10:5. doi: 10.3389/fendo.2019.00005. eCollection 2019.
8
Corrigendum: Association of Complement-Related Proteins in Subjects With and Without Second Trimester Gestational Diabetes.勘误：有和没有孕中期妊娠糖尿病的受试者中补体相关蛋白的关联
Front Endocrinol (Lausanne). 2021 Nov 9;12:781347. doi: 10.3389/fendo.2021.781347. eCollection 2021.
9
Corrigendum: Pioglitazone for NAFLD Patients With Prediabetes or Type 2 Diabetes Mellitus: A Meta-Analysis.勘误：吡格列酮用于患有前驱糖尿病或2型糖尿病的非酒精性脂肪性肝病患者：一项荟萃分析。
Front Endocrinol (Lausanne). 2022 Feb 16;13:840299. doi: 10.3389/fendo.2022.840299. eCollection 2022.
10
Corrigendum: ASK1-interacting protein 1 acts as a novel predictor of type 2 diabetes.勘误：ASK1相互作用蛋白1作为2型糖尿病的一种新型预测指标。
Front Endocrinol (Lausanne). 2022 Aug 16;13:981231. doi: 10.3389/fendo.2022.981231. eCollection 2022.

引用本文的文献

1
pir-hsa-216911 inhibit pyroptosis in hepatocellular carcinoma by suppressing TLR4 initiated GSDMD activation.pir-hsa-216911通过抑制TLR4启动的GSDMD激活来抑制肝细胞癌中的细胞焦亡。
Cell Death Discov. 2025 Jan 17;11(1):11. doi: 10.1038/s41420-024-02285-9.
2
Discovery of robust and highly specific microbiome signatures of non-alcoholic fatty liver disease.发现非酒精性脂肪性肝病强大且高度特异的微生物组特征。
Microbiome. 2025 Jan 14;13(1):10. doi: 10.1186/s40168-024-01990-y.
3
Metabolic memory: mechanisms and diseases.代谢记忆：机制与疾病
Signal Transduct Target Ther. 2024 Feb 28;9(1):38. doi: 10.1038/s41392-024-01755-x.
4
Epigenetics of methylation modifications in diabetic cardiomyopathy.糖尿病心肌病中甲基化修饰的表观遗传学
Front Endocrinol (Lausanne). 2023 Mar 15;14:1119765. doi: 10.3389/fendo.2023.1119765. eCollection 2023.
5
The DNAm levels of CREB5 (cg11301281) were associated with clopidogrel resistance.CREB5（cg11301281）的 DNAm 水平与氯吡格雷抵抗相关。
J Clin Lab Anal. 2022 Oct;36(10):e24690. doi: 10.1002/jcla.24690. Epub 2022 Sep 10.